SRD5A2 and prostate carcinoma: The enzyme steroidtype II 5-alpha-reductase (SRD5α2) isresponsible for the conversion of testosterone to dihydrotestosterone(DHT), which is involved in prostate cancer, benign prostatic hyperplasia,and androgenic alopecia.